Skip to main content

Pharmasset, Inc. Merger Under Investor Investigation

  • If you purchased shares of Pharmasset, Inc. (NASDAQ:VRUS) prior to the announcement and currently hold those shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

The announcement that Pharmasset, Inc. agreed to be acquired by Gilead Sciences, Inc for $137 per share prompted an investigation on behalf of investors of Pharmasset, Inc. (NASDAQ: VRUS) concerning whether the offer to acquire Pharmasset and the buyout process are unfair to investors of Pharmasset (NASDAQ:VRUS) and whether certain of its officers and directors or others breach their ...



You must register (for free) or login to view the entire investigation.